Company / AR per Share
NovoCure Ltd AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.82
FY2025
5-year range
$0.58 / $0.91
FY2021-FY2025
Trend
+18.9%
vs FY2024
Sector context
#115 of 141
Health Care
What the data says
NovoCure Ltd's ar per share of $0.82 is lower than 82% of companies in the Health Care sector (FY2025). Improved from $0.58 to $0.82 over the past 2 years.
Based on SEC 10-K filings.
0.82 in FY2025 with a 5-year CAGR of -3.2%.
Improved from $0.58 to $0.82 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -0.2%
- 5-Year CAGR
- -3.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 141This company $0.82 Sector average $11.78
▼
-93.0% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 18.9% year-over-year.
- Ranks #115 out of 141 companies in the Health Care sector.
- Peak ar per share was recorded in FY2020.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.82 | +18.9% |
| FY2024 | $0.69 | +18.9% |
| FY2023 | $0.58 | -29.8% |
| FY2022 | $0.83 | -9.3% |
| FY2021 | $0.91 | -5.9% |
| FY2020 | $0.97 | +53.9% |
| FY2019 | $0.63 | +54.6% |
| FY2018 | $0.41 | +20.2% |
| FY2017 | $0.34 | +348.8% |
| FY2016 | $0.08 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026